Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
06/2000
06/06/2000US6071861 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
06/02/2000WO2000031068A1 Polyhydroxylated heterocyclic derivatives as anti-coagulants
06/02/2000WO2000031045A1 Naphthalene derivatives
06/02/2000WO2000031044A1 Iminoguanidine derivatives, preparation method, use as medicines
06/02/2000WO2000031036A1 Novel naphthalene derivatives
06/02/2000CA2291880A1 Novel derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one, and compositions and methods for inhibiting abnormal cell growth comprising said derivatives
05/2000
05/31/2000EP1003726A1 Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests
05/31/2000EP1003541A1 Inhibitors of hiv reverse transcriptase
05/31/2000EP1003505A1 Heterocyclic vinylethers against neurological disorders
05/31/2000EP1003497A1 Il-8 receptor antagonists
05/31/2000EP0646005B1 Use of an imidazole for the preparation of a medicament for the treatment of arteriosclerosis
05/31/2000EP0633775B1 Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor
05/31/2000CN1255121A Selective epoxidation process for preparing pharmaceutical compounds
05/31/2000CN1255119A Protease inhibitors
05/31/2000CN1255042A Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
05/31/2000CN1254597A Antiswelling medicine
05/31/2000CN1052984C New erythromycin derivative and its preparing process and application in medicine
05/30/2000US6069283 Illudin analogs useful as antitumor agents
05/30/2000US6069275 A reaction product of hydroxyethyl methacrylate with alicylic diisocyanate followed by reaction of the monourethane product the n-aminoethyl ethylene urea; the formed copolymer for promoting wet adhesion of latex polymers for paints
05/30/2000US6069251 Highly selective partial agonists or antagonists at brain dopamine receptor subtypes or prodrugs; diagnosis and treatment schizophrenia; antidepressants; certain movement disorders such as parkinsonism.
05/30/2000US6069247 Reacting an acetylenecarboxy amide and an aryl or heterocyclyl halide or a group enhancing the electrophilicity of the atom to which it is attached for displacement; using a palladium compound catalyst, a base and an acid
05/30/2000US6069162 Indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production
05/25/2000WO2000029399A1 Antiherpes compounds
05/25/2000WO2000029376A1 Heteroarylthio compounds and cancer remedies containing the same
05/25/2000WO2000028988A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
05/25/2000DE19853842A1 New water-soluble compound formed between allantoin and glyoxylic acid useful in cosmetic and/or pharmaceutical formulations
05/25/2000CA2349575A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
05/24/2000EP1002544A1 Anti-edema agent
05/24/2000EP1001930A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
05/24/2000EP0817767B1 Bicyclic amine derivatives and their use as anti-psychotic agents
05/24/2000EP0626969B1 CoA-IT AND PAF INHIBITORS
05/24/2000CN1254337A N-hydroxy 4-sulfonyl butyramide compounds
05/24/2000CN1253954A Heterocyclic alkoxyl amine as regulator in controlled free radical polymerization method
05/24/2000CN1253775A Refractory vasculitis therapeutic preparation
05/23/2000US6066756 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them
05/23/2000US6066740 From thiourea intermediate; for treatment of respiratory disorders, ocular disorders, gastrointestinal disorders, nasal decongestion, hypertension, migraine, disorders associated with sympathetic nervous system activity, and substance abuse
05/23/2000US6066739 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same
05/23/2000US6066738 Inhibitors of farnesyl-protein transferase
05/23/2000US6066673 Enzyme inhibitors
05/23/2000US6066662 Use in control or prevention of rheumatoid arthritis and osteoarthritis or in the treatment of invasive tumours, atherosclerosis or multiple sclerosis
05/18/2000WO2000028131A2 Method for treating polyolefine- or polyester-based fibers to render them hydrophilic using heterocycles
05/18/2000WO2000027857A2 Novel erythromycin derivatives, preparation method and use as medicines
05/18/2000WO2000027823A1 Gastrin and cholecystokinin receptor ligands
05/18/2000WO2000027820A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
05/18/2000WO2000027378A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
05/18/2000WO2000009479A3 Heterocyclic thioesters or ketones for vision and memory disorders
05/18/2000WO2000006597A3 Endogenous constitutively activated g protein-coupled orphan receptors
05/18/2000WO2000004892A3 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
05/18/2000CA2348946A1 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
05/18/2000CA2346898A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
05/18/2000CA2346108A1 Gastrin and cholecystokinin receptor ligands
05/17/2000EP1000932A1 Aromatic ring derivatives
05/17/2000EP1000041A1 1,3-diaza- heterocycles and their use as nitric oxide synthase inhibitors
05/17/2000EP1000036A1 Hydantoin derivatives having an inhibitory activity for farnesyl transferase
05/17/2000EP1000031A1 Vitronectin receptor antagonist
05/17/2000EP1000029A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
05/17/2000EP1000025A1 Substituted naphthopyrans
05/17/2000EP1000023A2 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
05/17/2000EP0999835A1 Imidazole derivatives as mdr modulators
05/17/2000EP0848701B1 O-benzyl oxime ether derivatives and their use in crop protection compositions
05/17/2000EP0770066B1 Serotonin 5-ht 1a and dopamin d2 receptor ligands
05/17/2000CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds
05/17/2000CN1253554A Heterocyclic compounds and their use for inhibiting 'beta'-amyloid peptide
05/17/2000CN1253545A Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases
05/17/2000CN1253502A Method of using cyclooxygenase-2 inhibitors in prevention of cardiovascular disorders
05/17/2000CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/16/2000US6063934 Neuropeptide y antagonists
05/16/2000US6063930 For treatment of neurofibromin benign proliferative disorder, retinal vascularization blindness, viral diseases, restenosis, polycystic kidney disease
05/16/2000US6063928 Antiinflammatory agents, antiallergens, cardiotonic agents
05/16/2000CA2081637C Rhenium and technetium complexes containing a hypoxia-localizing moiety
05/13/2000CA2289327A1 An anti-edema agent
05/11/2000WO2000026212A1 Chromenone and chromanone derivatives as integrin inhibitors
05/11/2000WO2000026195A1 Novel amino acid heterocyclic amide derivatives useful as nitric oxide synthase inhibitors
05/11/2000WO2000025770A1 Carbocyclic potassium channel inhibitors
05/11/2000WO2000007542A3 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance p
05/11/2000DE19851685A1 Verfahren zur hydrophilen Ausrüstung von Fasern auf Basis von Polyolefinen oder Polyester unter Einsatz von Heterocyclen A process for the hydrophilic finishing of fibers based on polyolefins or polyester using heterocycles
05/10/2000EP0999205A1 Aminocycloalkane compounds
05/10/2000EP0998454A2 Metalloproteinase inhibitors
05/10/2000EP0998451A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
05/10/2000CN1252800A Farnesyltransferase inhibiting quinazolinones
05/10/2000CN1252799A N-heterocyclic derivatives as NOS inhibitor
05/10/2000CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252788A Process for preparing pharmaceutical compounds
05/10/2000CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1052231C 2-oxo-5-oxazolidone methyl compound their preparing method and medicinal composition containing them
05/09/2000US6060604 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
05/09/2000US6060586 Ureins derived from alpha, omega-diamono acids and process for their preparation
05/09/2000US6060502 Agriculture; pesticides for control of arthropods, helminths, nematodes, protozoa
05/09/2000US6060496 Long lasting at small dosages
05/09/2000US6060495 Pesticidal sulfur compounds
05/09/2000US6060476 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
05/09/2000US6060071 Ectoin and ectoin derivatives as moisturizers in cosmetics
05/09/2000US6060038 Radiolabeled farnesyl-protein transferase inhibitors
05/04/2000WO2000024763A1 Single morphic forms of known peptide metalloproteinase inhibitors
05/04/2000WO2000024707A1 Substituted phenyl derivatives, their preparation and use
05/04/2000WO2000024403A1 Use of antifungal agents for treating scleroses
05/04/2000WO2000024402A1 Use of antifungal agents for treating scleroses
05/04/2000WO2000007997A8 IMIDAZOLES AND RELATED COMPOUNDS AS α1A AGONISTS
05/04/2000WO1999063988A9 Inhibitors of nitric oxide synthase
05/04/2000WO1999062888A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss